The effects of sublingual nitroglycerin (GTN) on left ventricular wall motion (LVWM) were examined by angiographic assessment in eight patients with anginal chest pain. Five Materials and Methods Eight patients with suspected coronary artery disease (CAD) were studied. The protocol and purposes of the investigation were explained to each patient and an informed consent was obtained. The patients were not preselected on any specific criteria other than their willingness and ability to comply with the study protocol. Long-acting nitrites and propranolol were discontinued at least 24 hours prior to the study. Using standard catheterization techniques a flow-directed balloon tip catheter was passed via the right antecubital vein and positioned in the pulmonary artery and another electrode catheter in the coronary sinus in order to obtain consistent atrial pacing. A Brockenbrough
parameters, therefore, do not provide a consistent end point in the evaluation of pharmacologic agents. Angiocardiographic evaluation of left ventricular wall motion has revealed focal asynergy more consistently following the pacing "ischemic" stress, even in presence of a normal hemodynamic response. [12] [13] [14] The present study, therefore, was designed to evaluate angiographically the effect of nitroglycerin on left ventricular wall motion during acute myocardial ischemia induced by atrial pacing.
Materials and Methods
Eight patients with suspected coronary artery disease (CAD) were studied. The protocol and purposes of the investigation were explained to each patient and an informed consent was obtained. The patients were not preselected on any specific criteria other than their willingness and ability to comply with the study protocol. Long-acting nitrites and propranolol were discontinued at least 24 hours prior to the study. Using standard catheterization techniques a flow-directed balloon tip catheter was passed via the right antecubital vein and positioned in the pulmonary artery and another electrode catheter in the coronary sinus in order to obtain consistent atrial pacing. A Brockenbrough catheter was passed into the left atrium by the transseptal technique and subsequently advanced to the left ventricle. A cannula in the left brachial artery was used for recording of arterial pressures as well as a sampling site for indicator dilution curves. Pulmonary artery (PA), left ventricular (LV), and systemic arterial (SA) pressures were recorded simultaneously. High amplifier gain and rapid paper speed were used in order to facilitate measurement of the left ventricular end diastolic pressure (LVEDP). Cardiac outputs were determined using indocyanine green as the indicator.
Injections were made into the pulmonary artery with sampling from the brachial artery.
Procedures
Pressures and cardiac outputs were first obtained in the control state. Atrial pacing ("tachypacing") was then initiated at a rate which was approximately 10-15 beats/minute above the patient's resting rate. Subsequent pacing rates were increased at approximately 20 beats per minute up to a maximum of 150 beats/min or to the development of chest pain. Pressures and cardiac output were recorded 3 to 5 min after the initiation of each new pacing level. Pressures were also recorded during a brief interruption of each pacing. The LVEDP recorded during the interruption of pacing is the average value of eight consecutive beats beginning with the third beat after the interruption. After completion of this part of the study, pacing was discontinued, and followed by a 15 min recovery period. Atrial pacing was then reinstituted at the initial pacing rate (IPR) and a cineangiogram was performed in the right anterior oblique position (RAO) with injection into the left atrium (LA). The electrocardiogram was recorded during the injection to confirm the presence of pacemaker capture and to record anv arrhvthmias which occurred during the angiogram. Fifteen minutes after the first angiogram, the pacing rate was increased to that level at which the patient developed chest pain or to a maximal rate of 150 beats/minute. When the patient developed chest pain (usually 3-5 min of pacing), a second LA angiogram was done in the RAO position. The pacing was slowed to the IPR just prior to the injection. Pacing was then discontinued for a 20 min recovery period during which time angina was spontaneously relieved. Measurements of pressures and cardiac outputs were repeated at IPR and the patient was again paced at the rapid pace rate until the development of angina (3-5 min). Repeat measurements of pressure and flow were made before giving 0.3 mg of nitroglycerin (GTN) sublingually, as well as two minutes after the administration of GTN. A third LA angiogram was then performed in the same manner as previously described. All angiograms were done at the same heart rate. i.e., IPR, so that the cycle lengths were nearly identical.
A total of approximately 120 cc of radiographic dye (Renografin 76, Squibb) was used for the LV angiograms. This amount, which did not exceed 2 ml/kg in any patient, was given over a 45-60 min period. During the time of the entire study, the patients received 500-700 ml of dextrose solution for flushing the catheters. The time and use of intravenous fluids, in the Circulation, Volume XLIX, April 1974 presence of good renal function, should prevent any significant change in serum osmolality.
Selective coronary angiograms were done on each patient 24-48 hours after the study.
Data Analysis
Intracardiac pressures, cardiac index (Cl), and left ventricular stroke work index (LVSWI) were evaluated for each patient. Cineangiograms were interpreted independently by three observers for qualitative abnormalities of wall motion. Comparison of the control, "tachypace," and postnitroglycerin cineangiograms was facilitated by tracing the end diastolic anid end systolic ventricular outlines.
Results
The patients included in this study are divided on the basis of their response to nitroglycerin. Patients 1-6 had an improvement in left ventricular wall motion following nitroglycerin. Patient 7 had a questionable response, and patient 8 had atypical chest pain but normal wall motion and normal coronary arteries.
The hemodynamic data for all patients are summarized in table 1. Data are tabulated for the pre-pace control, rapid pace, and rapid pace post nitroglycerin (pace-T) periods.
The control LVEDP was elevated at rest in three patients (RP, DF, JR). During "tachypacing" two of these patients (RP, JR) had decrease in the end diastolic pressure; however, patient DF had an increase in the LVEDP which was further accentuated during the brief interruption of pacing. In one patient (JE) a normal resting LVEDP became elevated with "tachypacing." Following GTN the LVEDP decreased or remained within the normal range in the seven patients on whom the data were available. The most dramatic reductions in LVEDP were seen during the pace interrupt recordings where the end diastolic pressures were more easily determined.
During "tachypacing" the systemic arterial pressure increased in six patients. Following nitroglycerin seven patients had significant reduction in mean systolic arterial pressure. The low resting CI in four patients (DF, LH, MA, BC) showed little change during atrial pacing. Following nitroglycerin the CI fell in all seven patients in whom it was measured.
The LVSWI was reduced by rapid pacing with a further reduction following GTN in all patients.
During "tachypacing" all patients developed chest pain similar to that which they had complained of prior to hospitalization. Each Since that time many studies2-1" have reported on the hemodynamic, electrocardiographic, and metabolic changes associated with "tachypacing" induced myocardial ischemia. However, many patients with severe coronary artery disease do not show hemodynamic or metabolic abnormalities with "tachypacing" despite the development of chest pain and ST segment depression. In the present study only two patients developed an elevation of the LVEDP with "tachypacing" and only one patient had a further increase in LVEDP during the interruption of pacing. Comparison of the LVEDP with the LVSWI resulted in abnormal "pacing function curves" in these two patients.
Several reports3 5, 10 have shown that nitroglycerin effectively relieves the symptomatic complaints and improves the hemodynamic and electrocardiographic abnormalities associated with tachypacing induced myocardial ischemia. Chiong 
